Anagrelide recalls

The FDA has published 4 recalls involving Anagrelide since 2014. The latest was reported on 8 Jun 2022. Most were for potency & assay. Torrent Pharma has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2014

Last 12 months0reported

Class I250% of total

Ongoing0latest 8 Jun 2022

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 2 50%Class II 2 50%Class III 0 0%

Why anagrelide is recalled

Potency & Assay375%
Labeling Errors125%

Companies

By year

2022125%
2020125%
2019125%
2014125%

All anagrelide recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
8 Jun 2022Drug	CLASS I	Anagrelide Capsules USP, 0.5 mg recalled by Teva Pharmaceuticals USA	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
9 Dec 2020Drug	CLASS I	Anagrelide Capsules, USP 1 mg recalled by Torrent PharmaAnagrelide	Torrent Pharma	Potency & Assay	Nationwide
25 Sep 2019Drug	CLASS II	Anagrelide Capsules, USP, 0.5 mg recalled by Torrent PharmaAnagrelide	Torrent Pharma	Potency & Assay	Nationwide
29 Jan 2014Drug	CLASS II	Anagrelide HCL, Capsule, 0.5 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states

Should you stop taking Anagrelide?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.